Chemoprevention of Colorectal Cancer in Inflammatory Bowel Disease / 대한소화기학회지
The Korean Journal of Gastroenterology
;
: 3-10, 2014.
Artículo
en Coreano
| WPRIM
| ID: wpr-155062
ABSTRACT
The risk of developing colorectal cancer is increased in patients with inflammatory bowel disease. Surveillance colonoscopy has not been shown to prolong survival and rates of interval cancer are reported to be high. Continuing colonic inflammation has been shown to be important in the development of colorectal cancer and therefore anti-inflammatory agents such as the 5-aminosalicylates and immunomodulators have been considered as potential chemopreventive agents. This review focuses on various chemopreventive agents that have been clearly shown to reduce the risk of colorectal adenoma and cancer in the patients with inflammatory bowel disease.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Asunto principal:
Ácido Ursodesoxicólico
/
Neoplasias Colorrectales
/
Enfermedades Inflamatorias del Intestino
/
Quimioprevención
/
Mesalamina
/
Ácido Fólico
/
Inmunosupresores
/
Antiinflamatorios
Idioma:
Coreano
Revista:
The Korean Journal of Gastroenterology
Año:
2014
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS